122 related articles for article (PubMed ID: 3535934)
1. [Cancer of the prostate: current status of chemotherapy].
Bollak C; Bergerat JP; Jacquemin D
Bull Cancer; 1986; 73(1):61-4. PubMed ID: 3535934
[TBL] [Abstract][Full Text] [Related]
2. The role of chemotherapy in prostate cancer. Minireview.
Odrázka K; Vanásek J; Vaculíková M; Stejskal J; Filip S
Neoplasma; 2000; 47(4):197-203. PubMed ID: 11043822
[TBL] [Abstract][Full Text] [Related]
3. Estramustine-based chemotherapy.
Hudes G
Semin Urol Oncol; 1997 Feb; 15(1):13-9. PubMed ID: 9050135
[TBL] [Abstract][Full Text] [Related]
4. The present role of estramustine phosphate in advanced prostate cancer.
Van Poppel H; Baert L
Prog Clin Biol Res; 1991; 370():323-41. PubMed ID: 1924466
[TBL] [Abstract][Full Text] [Related]
5. Achieving treatment goals for hormone-refractory prostate cancer with chemotherapy.
Berry W; Eisenberger M
Oncologist; 2005; 10 Suppl 3():30-9. PubMed ID: 16368869
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of hormonally unresponsive prostatic carcinoma.
deKernion JB; Lindner A
Urol Clin North Am; 1984 May; 11(2):319-26. PubMed ID: 6233779
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for androgen-independent prostate cancer.
Gulley J; Figg WD; Dahut WL
Clin Adv Hematol Oncol; 2003 Jan; 1(1):49-57. PubMed ID: 16227960
[TBL] [Abstract][Full Text] [Related]
8. EMP combination chemotherapy and low-dose monotherapy in advanced prostate cancer.
Kitamura T; Nishimatsu H; Hamamoto T; Tomita K; Takeuchi T; Ohta N
Expert Rev Anticancer Ther; 2002 Feb; 2(1):59-71. PubMed ID: 12113067
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy: is it effective in treatment of prostatic cancer?
Murphy GP
Urology; 1984 Nov; 24(5 Suppl):41-7. PubMed ID: 6388094
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of prostatic cancer].
Portnoĭ AS
Vopr Onkol; 1985; 31(9):3-12. PubMed ID: 2931901
[No Abstract] [Full Text] [Related]
11. Chemotherapy in advanced prostate cancer.
Beedassy A; Cardi G
Semin Oncol; 1999 Aug; 26(4):428-38. PubMed ID: 10482185
[TBL] [Abstract][Full Text] [Related]
12. Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
Thall PF; Logothetis C; Pagliaro LC; Wen S; Brown MA; Williams D; Millikan RE
J Natl Cancer Inst; 2007 Nov; 99(21):1613-22. PubMed ID: 17971530
[TBL] [Abstract][Full Text] [Related]
13. Immunotherapy for prostate cancer - recent progress in clinical trials.
Kipp RT; McNeel DG
Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921
[TBL] [Abstract][Full Text] [Related]
14. Phase III multi-institutional trial of adjuvant chemotherapy with paclitaxel, estramustine, and oral etoposide combined with long-term androgen suppression therapy and radiotherapy versus long-term androgen suppression plus radiotherapy alone for high-risk prostate cancer: preliminary toxicity analysis of RTOG 99-02.
Rosenthal SA; Bae K; Pienta KJ; Sobczak ML; Asbell SO; Rajan R; Kerlin KJ; Michalski JM; Sandler HM;
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):672-8. PubMed ID: 18990504
[TBL] [Abstract][Full Text] [Related]
15. [Advanced prostate cancer--a therapeutic dilemma?].
Rübben H; Altwein JE
Urologe A; 1987 Jan; 26(1):7-14. PubMed ID: 3576864
[TBL] [Abstract][Full Text] [Related]
16. Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer.
Galsky MD; Small EJ; Oh WK; Chen I; Smith DC; Colevas AD; Martone L; Curley T; Delacruz A; Scher HI; Kelly WK
J Clin Oncol; 2005 Mar; 23(7):1439-46. PubMed ID: 15735119
[TBL] [Abstract][Full Text] [Related]
17. Management of hormone refractory prostate cancer: current standards and future prospects.
Oh WK; Kantoff PW
J Urol; 1998 Oct; 160(4):1220-9. PubMed ID: 9751323
[TBL] [Abstract][Full Text] [Related]
18. Is there a role for platinum chemotherapy in the treatment of patients with hormone-refractory prostate cancer?
Oh WK; Tay MH; Huang J
Cancer; 2007 Feb; 109(3):477-86. PubMed ID: 17186531
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of prostatic cancer.
Schmidt JD
Urol Clin North Am; 1975 Feb; 2(1):185-96. PubMed ID: 1093059
[TBL] [Abstract][Full Text] [Related]
20. Treatment options in androgen-independent prostate cancer.
Lara PN; Meyers FJ
Cancer Invest; 1999; 17(2):137-44. PubMed ID: 10071598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]